Alex Zhavoronkov· biogerontology·· 6 天前AI 评分22
Insilico神经衰老靶点发现
AI-enabled target discovery in neuro aging turns a hard indication class into named next-generation targets partners can diligence. Iosif...
AI 导读
在神经衰老领域，AI驱动的靶点发现将一类难成药适应证转化为可命名的下一代靶点，供合作伙伴尽职调查。Iosif M. Gershteyn 于 #ARDD2026 演讲。照片：https://agingpharma.org/photos2026
来源：Alex Zhavoronkov · x.com